{
    "paper_id": "0775644af19e13cb5a4214be4db3f8ad75acd2d4",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "\u2022 COVID-19: the disease caused by SARS-CoV-2 and was named by the World Health Organization (WHO) on Feb 11, 2020. \"CO\" refers to corona, \"VI\" to virus, and \"D\" to disease, while \"19\" designates the year of initial discovery of this disease.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 Covid-19 refers to the disease while SARS-CoV-2 refers to the virus that causes the disease. However, the WHO sometimes uses the term \"COVID-19 virus\" for the virus instead of its official name of \"SARS-CoV-2\".",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "\u2022 SARS-CoV-2 virus binds to Angiotensin-Converting Enzyme II (ACE2) in the alveolae of the lung to gain entry into the host cells [2, 3] \u2022 ACE2 receptors also exist in heart, kidney, gastrointestinal tract (GI) tract, urinary systems [4] , and even oral mucosa (especially in the oral tongue) [5] \u2022 These findings indicate that the organs with high ACE2-expressing cells should be considered as potential high risk for SARS-CoV-2 infection",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 133,
                    "text": "[2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 134,
                    "end": 136,
                    "text": "3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 234,
                    "end": 237,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 293,
                    "end": 296,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "How does coronavirus affect the human body?"
        },
        {
            "text": "\u2022 COVID-19 is a lower airway disease. Most common symptoms (viral-related) include fever, coughing (often dry a cough initially, generally becoming productive later), muscle aches, fatigue, and shortness of breath [6, 7] .",
            "cite_spans": [
                {
                    "start": 214,
                    "end": 217,
                    "text": "[6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 218,
                    "end": 220,
                    "text": "7]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "\u2022 A very recent study suggests that digestive symptoms such as loss of appetite and diarrhea are also common [8] \u2022 In contrast, upper airway catarrh syndrome, such as running nose or sneezing, are rare in COVID-19 patients [9] \u2022 According to the WHO, the three most common symptoms for COVID-19 are: fever, tiredness, and dry cough [10]",
            "cite_spans": [
                {
                    "start": 109,
                    "end": 112,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 223,
                    "end": 226,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "\u2022 In addition to respiratory symptoms, some COVID-19 patients may exhibit GI symptoms [8] ,",
            "cite_spans": [
                {
                    "start": 86,
                    "end": 89,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "suggesting unexplained diarrhea and may also be considered for screening",
            "cite_spans": [],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "\u2022 Recently, the American Academy of Otolaryngology -Head and Neck Surgery also recommended adding \"sudden loss of taste or smell\" as one of the symptoms for screening of COVID-19 [11] 4. How long does it usually take from infection to recovery?",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 183,
                    "text": "[11]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "\u2022 The median time from symptom to recovery is 22 days in survivors and median duration of viral shedding is 20 days (longest 37 days) [12] \u2022 This information is useful for the strategic planning of cancer treatment during the COVID-19 outbreak:",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 138,
                    "text": "[12]",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "Delaying cancer treatment for COVD-19 positive cancer patients may be feasible for certain cancers, if expected delay is about 4 weeks",
            "cite_spans": [],
            "ref_spans": [],
            "section": "What symptom should I pay more attention to when I screen a patient?"
        },
        {
            "text": "\u2022 COVID-19 virus can spread via respiratory mucus or saliva droplets (coughing and talking), contact with bodily fluids (e.g. saliva, vomitus, etc), or from contaminated surfaces [13] . There is no convincing clinical evidence of aerosol spread although in vitro experiments suggested that aerosol spread cannot be fully ruled out [14] (to be discussed later)",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 183,
                    "text": "[13]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 331,
                    "end": 335,
                    "text": "[14]",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "Differences between respiratory \"droplets\" and \"aerosol\" depend on the size of the particles and duration of suspension in the air. Respiratory droplets are generally and arbitrarily defined as > five \u00b5m in diameter while aerosol particles are considered as \u2264 five \u00b5m in diameter. These size partitions are still in discussion without complete agreement among groups [15] .",
            "cite_spans": [
                {
                    "start": 367,
                    "end": 371,
                    "text": "[15]",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "\u2022 The most common route of viral transmission is through close contact with infectious secretions (sputum, serum, blood, and respiratory droplets) from a COVID-19 patient",
            "cite_spans": [],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "\u2022 Mucosal surfaces of the face including nose, mouth, and eyes (often forgotten by most people)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "can all be the entrance portal for the COVID-19 virus",
            "cite_spans": [],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "\u2022 Close contact increases risk of viral contraction:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "Close contact is defined by the United States (US) Centers for Disease Control and Prevention (CDC) as: being within 2 meters of a COVID-19 patient for a prolonged period of time [16] \u2022 Recent investigation shows that the COVID-19 virus may suspend in the air for two to three hours (depending on heat and humidity, and presumably air flow), and exist on external surfaces for more than three days (more stable on plastic and stainless steel than on copper and carboard) [14] Exercising good hand hygiene is very important to avoid SARS-CoV-2 entering the eyes, nose and mouth after touching an infected surface",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 183,
                    "text": "[16]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 471,
                    "end": 475,
                    "text": "[14]",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "Since the COVID-19 virus can stay suspended in the air for two to three hours depending on humidity, heat, and airflow [14] , WHO advises that \"airborne precautions\" should be considered for health care professionals (HCPs)",
            "cite_spans": [
                {
                    "start": 119,
                    "end": 123,
                    "text": "[14]",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "CDC and Public Health Ontario now recommend \"airborne precautions\" for HCPs when performing aerosol generating medical procedures for all suspicious or confirmed COVID-19 patients [17, 18] 6. What is my risk and how I can minimize the risk of getting infected?",
            "cite_spans": [
                {
                    "start": 180,
                    "end": 184,
                    "text": "[17,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 185,
                    "end": 188,
                    "text": "18]",
                    "ref_id": "BIBREF16"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "\u2022 Health care professionals (HCPs) are at high risk since a recent study shows that a substantial proportion of virus spread occurs in the asymptomatic or pre-symptomatic phase [13] \u2022 Personal protective equipment (PPE) including eye shielding is an essential first step [19] . \u2022 Disinfection procedures should be established for floor and walls, surfaces, air, and \"spills\"/disposals [21] \u2022 When talking to a patient, keep your distance (preferably two meters when possible) with patients since we do not know who may be an asymptomatic viral carrier.",
            "cite_spans": [
                {
                    "start": 177,
                    "end": 181,
                    "text": "[13]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 271,
                    "end": 275,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 385,
                    "end": 389,
                    "text": "[21]",
                    "ref_id": "BIBREF18"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "Notably studies have shown that the risk of droplet transmission as defined above (i.e. > five \u00b5m in diameter), is very low beyond one to two metres [15] Radiation therapy:",
            "cite_spans": [
                {
                    "start": 149,
                    "end": 153,
                    "text": "[15]",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "\u2022 A recent publication from China shared specific practice guidelines and treatment workflow for radiotherapy during COVID-19 outbreak [20] :",
            "cite_spans": [
                {
                    "start": 135,
                    "end": 139,
                    "text": "[20]",
                    "ref_id": "BIBREF17"
                }
            ],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "Health education for patients: informing about the risk of cross-contamination, zoning design and workflow of radiotherapy during the outbreak Zoning: A radiotherapy center should be divided into a \"Clean Zone\", \"Semi-soiled/semicontaminated Zone\", and \"Soiled/contaminated Zone\" with clearly defined protection measures for each zone Special consideration should be paid to disinfection of immobilization devices ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "How is the virus transmitted?"
        },
        {
            "text": "\u2022 SARS-CoV-2 viruses are extremely vulnerable to solvent and detergents (e.g. soap) to break down the viral membrane [22] Washing hands with soap for a sufficient period (>20 minutes) is effective to kill SARS-CoV-2",
            "cite_spans": [
                {
                    "start": 117,
                    "end": 121,
                    "text": "[22]",
                    "ref_id": "BIBREF19"
                }
            ],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 SARS-CoV-2 viruses are also sensitive to heat (about 60 C\u00b0) as shown in several experiments because heating could denature proteins [23, 24] \u2022 The viruses can be effectively inactivated by surface disinfection procedures with 62-71% ethanol (alcohol), 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within one minute [25] \u2022 Other disinfectants for use against COVID-19 virus are listed via the US EPA website: [26] \u2022 UV-C light is reported to be effective to kill >99% of other coronavirus (MERS-CoV and SARS-CoV) in 10 minutes [27] , and has been used in some Chinese Hospitals as a disinfection method [21] 9. What is the incubation period for COVID-19?",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 138,
                    "text": "[23,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 139,
                    "end": 142,
                    "text": "24]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 323,
                    "end": 327,
                    "text": "[25]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 416,
                    "end": 420,
                    "text": "[26]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 534,
                    "end": 538,
                    "text": "[27]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 610,
                    "end": 614,
                    "text": "[21]",
                    "ref_id": "BIBREF18"
                }
            ],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 Generally, the median incubation period for COVID-19 is approximately 5.1 days (mean 5.5 days)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 In 97.5% of infected persons, symptoms appear within 12 days [28] \u2022 Screening for a travel history of 14 days and current symptoms will catch the majority of COVID-19 patients",
            "cite_spans": [
                {
                    "start": 63,
                    "end": 67,
                    "text": "[28]",
                    "ref_id": "BIBREF25"
                }
            ],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 However, emerging evidence suggests that a proportion of viral transmission could occur before symptom onset [29] [30] [31] \u2022 Some small studies suggested that asymptomatic viral carriers may be infectious for up to three weeks [29] 10. How contagious is the COVID-19 Virus compared to other coronaviruses?",
            "cite_spans": [
                {
                    "start": 111,
                    "end": 115,
                    "text": "[29]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 116,
                    "end": 120,
                    "text": "[30]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 121,
                    "end": 125,
                    "text": "[31]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 230,
                    "end": 234,
                    "text": "[29]",
                    "ref_id": "BIBREF26"
                }
            ],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 The transmutability of a virus is measured using the \"reproduction number\" (R0). This is measured by the number of individuals affected by one viral carrier. The higher the R0, the more transferable the virus is and the higher the risk for rapid spread.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 The WHO initial estimation of R0 for SARS-COV-2 is 1.4-2.5 [2] \u2022 However recent review shows that the mean R0 for COVID-19 Virus is 3.3, and a median of 2.8 [32] \u2022 There are at least two strains of SARS-CoV-2: S type (the older version) and L type (the newer strain). L type seems more aggressive and the virus spread is more rapid [33] 11. How can MRTs protect their family?",
            "cite_spans": [
                {
                    "start": 61,
                    "end": 64,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 159,
                    "end": 163,
                    "text": "[32]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 334,
                    "end": 338,
                    "text": "[33]",
                    "ref_id": "BIBREF30"
                }
            ],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 \u2022 ACE inhibitors or ARBs: Several researchers observed an association between ACE inhibitors and severity of COVID-19 [6] and proposed a hypothesis that ACE inhibitors could act as a potential risk factor for COVID-19 by up-regulating ACE2 [34, 35] . However, others believe that the current data has not proven its causation and recommend against cessation of this antihypertension medication [36] .",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 123,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 242,
                    "end": 246,
                    "text": "[34,",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 247,
                    "end": 250,
                    "text": "35]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 396,
                    "end": 400,
                    "text": "[36]",
                    "ref_id": "BIBREF33"
                }
            ],
            "ref_spans": [],
            "section": "What are some useful disinfection measures for SARS-CoV-2?"
        },
        {
            "text": "\u2022 Mostly supportive care",
            "cite_spans": [],
            "ref_spans": [],
            "section": "What is the effective treatment for COVID-19?"
        },
        {
            "text": "\u2022 Two drugs recently received FDA approval for \"compassionate use\" (i.e. \"expanded access\"):",
            "cite_spans": [],
            "ref_spans": [],
            "section": "What is the effective treatment for COVID-19?"
        },
        {
            "text": "chloroquine/hydroxychloroquine and remdesivir for treatment of COVID-19 based on some preliminary promising clinical data [37] [38] [39] , but their ultimate value remains uncertain",
            "cite_spans": [
                {
                    "start": 122,
                    "end": 126,
                    "text": "[37]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 127,
                    "end": 131,
                    "text": "[38]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 132,
                    "end": 136,
                    "text": "[39]",
                    "ref_id": "BIBREF36"
                }
            ],
            "ref_spans": [],
            "section": "What is the effective treatment for COVID-19?"
        },
        {
            "text": "When an individual has recovered from SARS-CoV-2, could he/she get re-infected?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "14."
        },
        {
            "text": "\u2022 A recent animal model experiment (on monkeys) shows that primary SARS-CoV-2 infection could protect an individual from subsequent infection [40] \u2022 The duration of the putative protection remains unknown. ",
            "cite_spans": [
                {
                    "start": 142,
                    "end": 146,
                    "text": "[40]",
                    "ref_id": "BIBREF37"
                }
            ],
            "ref_spans": [],
            "section": "14."
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2",
            "authors": [],
            "year": 2020,
            "venue": "Nat Microbiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Autoimmun",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "579",
            "issn": "7798",
            "pages": "270--273",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Front Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Oral Sci",
            "volume": "12",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Gastroenterology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "507--513",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "AAO-HNS: Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Protecting health-care workers from subclinical coronavirus infection",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "8",
            "issn": "3",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Van Doremalen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "Y C"
                    ],
                    "last": "Shiu",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "H L"
                    ],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Cowling",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Curr Opin Infect Dis",
            "volume": "32",
            "issn": "4",
            "pages": "372--379",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential Coronavirus Disease 2019 (COVID-19) Exposures: Geographic Risk and Contacts of Laboratory-confirmed Cases",
            "authors": [],
            "year": 2020,
            "venue": "Ceters for Disease Control and Prevention (CDC)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "WHO considers 'airborne precautions' for medical staff after study shows coronavirus can survive in air",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Updated IPAC Recommendations for Use of Personal Protective Equipment for Care of Individuals with Suspect or Confirmed COVID-19",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Ontario",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Radiotherapy care during a major outbreak of COVID-19 in Wuhan. Advances in Radiation Oncology",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Handbook of COVID-19 Prevention and Treatment",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "U S O"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Darnell",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Transfusion",
            "volume": "46",
            "issn": "10",
            "pages": "1770--1777",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Heat sensitivity of a SARS-associated coronavirus introduced into plasma products",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yunoki",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Vox Sang",
            "volume": "87",
            "issn": "4",
            "pages": "302--305",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Coronavirus Disease 2019: Coronaviruses and Blood Safety",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Transfus Med Rev",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kampf",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Hosp Infect",
            "volume": "104",
            "issn": "3",
            "pages": "246--251",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Disinfectants for Use of Aginst SARS-CoV-2. 2020",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "P A U"
                    ],
                    "last": "Epa)",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Efficacy of an Automated Multiple Emitter Whole-Room Ultraviolet-C Disinfection System Against Coronaviruses MHV and MERS-CoV",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bedell",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Buchaklian",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Infect Control Hosp Epidemiol",
            "volume": "37",
            "issn": "5",
            "pages": "598--607",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Lauer",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ann Intern Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "China. Sci China Life Sci",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Mizumoto",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro Surveill",
            "volume": "",
            "issn": "10",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Nishiura",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "The reproductive number of COVID-19 is higher compared to SARS coronavirus",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Travel Med",
            "volume": "27",
            "issn": "2",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "On the origin and continuing evolution of SARS-CoV-2",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Karakiulakis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Roth",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Preventing a covid-19 pandemic",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Watkins",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "368",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Kuster",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Eur Heart J",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Dai",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Tong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Antimicrob Chemother",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "First Case of 2019 Novel Coronavirus in the United States",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Holshue",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "10",
            "pages": "929--936",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gautret",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "International Journal of Antimicrobial Agents",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Reinfection could not occur in SARS-CoV-2 infected rhesus macaques",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "We Know So Far (As of March 26, 2020) About COVID-19 -An MRT Point of View 1. What is the difference among the terms \"2019 novel coronavirus\", \"SARS-CoV-2\" and \"COVID-19\" and \"COVID-19 Virus\"? \u2022 2019 Novel Coronavirus (2019-nCOV) is a temporary unofficial name of the novel coronavirus that caused the severe acute respiratory syndrome (SARS) outbreak in Wuhan, China in 2019. \u2022 SARS-CoV-2: the official name of 2019-nCOV, with nomenclature determined by the International Committee on Taxonomy of Viruses [1]. The \"SARS\" part of the name refers to the new coronavirus' genetic link to the virus that caused the 2003 SARS outbreak.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "MRTs should follow institutional guidelines for use of PPE and exercise good hand hygiene Protect eyes, mouth and nose with masks, face shields, gowns, gloves Avoid having their hands directly touch surfaces Practice good hand hygiene 7. What strategies should departments consider to minimize the risk of intra-departmental COVID-19 transmission? \u2022 In addition to wearing PPE, and practicing good hand hygiene, keep your face as far away from your patients as possible, and avoid directly facing a patient's nose and mouth \u2022 Develop staff training programs \u2022 Screen patients and staff",
            "latex": null,
            "type": "figure"
        },
        "TABREF1": {
            "text": "Consider using hospital issued surgical scrubs at work and leaving them at work for hospital wash \u2022 Do not wear scrubs on public transportation and at home \u2022 Leave your coat and shoes at the door, away from living areas \u2022 For disinfection, CDC recommends dilute household bleach solutions, alcohol solutions with at least 70% alcohol, and most common EPA-registered household disinfectants Five tablespoons (1/3rd cup) bleach per gallon of water or Four teaspoons bleach per quart of water \u2022 Separate the dirty scrubs from normal clothing \u2022 Launder items using the hottest appropriate water setting12. What are controversies about some medications during the COVID-19 outbreak?\u2022 Ibuprofen and Acetaminophen: France has reported that non-steroidal anti-inflammatory medication (NSAIDS), such as ibuprofen, might aggravate symptoms of COVID-19, hence, suggesting avoidance of their use. However, the Food and Drug Administration (FDA) and WHO feel that more evidence is needed and have not recommended avoiding ibuprofen to treat COVID-19 symptoms",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Author: Shao Hui Huang Correspondence: Shao Hui Huang, MRT(T), MD, MSc Department of Radiation Oncology Princess Margaret Cancer Centre, University of Toronto Toronto, Canada Shaohui.huang@rmp.uhn.ca",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}